0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Pharmacology

Buy Now

Safety Evaluation of Biotechnologically-derived Pharmaceuticals - Facilitating a Scientific Approach (Paperback, Softcover reprint of the original 1st ed. 1998) Loot Price: R2,771
Discovery Miles 27 710
Safety Evaluation of Biotechnologically-derived Pharmaceuticals - Facilitating a Scientific Approach (Paperback, Softcover...

Safety Evaluation of Biotechnologically-derived Pharmaceuticals - Facilitating a Scientific Approach (Paperback, Softcover reprint of the original 1st ed. 1998)

Susan A. Griffiths, C. Lumley

Series: Centre for Medicines Research Workshop

 (sign in to rate)
Loot Price R2,771 Discovery Miles 27 710 | Repayment Terms: R260 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Against Period Poverty

Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.

General

Imprint: Springer
Country of origin: Netherlands
Series: Centre for Medicines Research Workshop
Release date: October 2012
First published: 1998
Editors: Susan A. Griffiths • C. Lumley
Dimensions: 240 x 160 x 12mm (L x W x T)
Format: Paperback
Pages: 200
Edition: Softcover reprint of the original 1st ed. 1998
ISBN-13: 978-9401060431
Categories: Books > Law > Laws of other jurisdictions & general law > Social law > General
Books > Medicine > General issues > Public health & preventive medicine > General
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 9401060436
Barcode: 9789401060431

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Progress in Medicinal Chemistry, Volume…
G. Lawton, David R. Witty Hardcover R4,601 Discovery Miles 46 010
KD Tripathi's MCQs in Pharmacology
R Prasan Bhandari Paperback R857 Discovery Miles 8 570
Pharmacy Practice
Kevin M.G. Taylor, Geoffrey Harding Paperback R2,525 Discovery Miles 25 250
Microencapsulation
Bartosz Tylkowski, Marta Giamberini, … Hardcover R5,513 Discovery Miles 55 130
Metal Ions in Bio-Imaging Techniques
Astrid Sigel, Eva Freisinger, … Hardcover R7,593 Discovery Miles 75 930
An Account of the Foxglove, and Some of…
William Withering Paperback R434 Discovery Miles 4 340
An Account of the Foxglove and Some of…
William Withering Paperback R434 Discovery Miles 4 340
On the Preparation and Medicinal…
Alexander Turnbull Paperback R331 R314 Discovery Miles 3 140
Heterocyclic Anticancer Agents
Bimal Krishna Banik, Bubun Banerjee Hardcover R6,230 Discovery Miles 62 300
Palliative Care Formulary
Andrew Wilcock, Paul Howard Paperback R1,891 Discovery Miles 18 910
Pharmaceutical Formulation Design…
Usama Ahmad, Juber Akhtar Hardcover R3,460 R3,232 Discovery Miles 32 320
Drugs in Use - Case Studies for…
Linda J. Dodds Paperback R1,282 Discovery Miles 12 820

See more

Partners